Clinical Trials
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Trials & Filings
Valneva COVID Vax Meets Co-primary Endpoints in Phase III Trial
Inactivated, adjuvanted VLA2001 demonstrates superiority against AZD1222 in terms of neutralization antibodies.10.18.21
-
Clinical Trials | Drug Development | R&D
Outsourcing R&D in Today's Market
Nick Lakin of Syneos Health Consulting discusses pharma/biopharma R&D trends, challenges the industry faces, and motivating factors for outsourcing.Online Exclusives Kristin Brooks, Managing Editor 10.18.21
-
Clinical Trials | Information Technology
How to Run Decentralized Clinical Trials in the Complex Web of Data Protection
Lessons learned from operationalizing hybrid DCT solutions across the globe.Ronan Brown, Ph.D., Head of Decentralized Trials Solutions at IQVIA 10.18.21
-
Breaking News | Clinical Trials | Preclinical Outsourcing
Evergreen Theragnostics Opens New Mfg. Facility in Springfield, NJ
Newly built 14,000 sq.-ft. facility ready to serve the manufacturing needs of companies developing and commercializing radiopharmaceuticals.10.18.21
-
Breaking News | Clinical Trials | Industry News
Caris, Ono Enter Strategic Molecular Profiling Pact
Will leverage Caris' novel, blood-based cNAS molecular profiling assay across several Ono clinical studies.10.15.21
-
Breaking News | Clinical Trials | CRO News
ObsEva, Syneos Health Partner to Commercialize Linzagolix
Linzagolix, an oral GnRH antagonist, is pending regulatory approval in the U.S. and Europe for the treatment of uterine fibroids.10.13.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development | Trials & Filings
AstraZeneca Submits EUA for LAAB Combo for COVID Prevention
Results from the PROVENT pre-exposure prophylaxis trial showed AZD7442 reduced the risk of developing symptomatic COVID-19 by 77%.10.07.21
-
Breaking News | Clinical Trials | CRO News | Information Technology
Syneos Health Acquires RxDataScience
Acquisition adds AI and data engineering expertise, enterprise analytics and tech-enabled solutions.10.06.21
-
Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Enteris Completes Phase 1 Trial of Optimized Peptelligence Oral Leuprolide
Data indicates that the formulation delivers comparable or greater drug levels than subcutaneous or depot injection.10.05.21
-
Bioanalytical Services | Clinical Trials | CRO News
BioAgilytix, CTI Ink Global Clinical Services Pact
To provide customers with mutually complementary services to streamline the client experience across the full spectrum of lifecycle development.10.04.21
-
Clinical Trials
5 Ways that Decentralized Clinical Trial Approaches Can Reduce Study Costs
The use of decentralized clinical trials is on the rise. Read THREAD's report on 5 ways to reduce study costs.
-
Breaking News | Clinical Trials | Drug Development
Brooks Rebrands Life Sciences Services and Products Biz as Azenta
New brand enables breakthroughs to market with a fully integrated portfolio for sample exploration and management solutions.09.28.21
-
Breaking News | Clinical Trials
pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
According to the study, the novel prophylactic nasal spray prevented infection from SARS-CoV-2, the virus that causes COVID-19.09.22.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials
Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany
Covers the combination of DHODH inhibitors and nucleoside analogues to treat viral infections, including Covid-19.09.22.21
-
Breaking News | Clinical Trials
First Patient is Dosed with Triumvira's Investigational TAC-T Cell Adoptive Immunotherapy
TAC01-HER2 was developed for the treatment of HER2-overexpressing cancers.09.21.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News | Parenterals
BioVaxys Reports Progress on Covid-19 Vax Candidate
Bioproduction partner Wuxi Biologics completes synthesis of recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH programs.09.16.21
-
Breaking News | Clinical Trials
Syneos Health Acquires Clinical Trial Recruitment and Retention Company StudyKIK
Accelerates product development by better connecting patients, sites and communities.09.15.21
-
Breaking News | Clinical Trials | Collaborations & Alliances
Hookipa Enters Clinical Collaboration & Supply Agreement with Merck & Co.
Will evaluate HB-200 in combination with Keytruda (pembrolizumab) in patients with advanced head and neck cancers.09.15.21
-
Clinical Trials | Drug Development
Supporting Product Regulatory Decision Making with RWE
Leveraging powerful evidence that can be instrumental in filling knowledge gaps for regulatory submissions.Nancy Dreyer, Chief Scientific Officer at IQVIA Real World Solutions 09.10.21
-
Clinical Trials
The Future of Clinical Trials
Dr. Greg Licholai of ICON plc on key market trends, the future of clinical trials and the acquisition of PRA.Kristin Brooks, Managing Editor 09.09.21
